Healthcare provider profile · identity verified

Greg C Randall, MD

Family Practice · LAKEVILLE, MN · NPI 1255333662

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	342	104
Lisinopril	Lisinopril	295	90
Metoprolol Succinate	Metoprolol Succinate	180	57
Losartan Potassium	Losartan Potassium	175	54
Simvastatin	Simvastatin	168	51
Amlodipine Besylate	Amlodipine Besylate	167	49
Omeprazole	Omeprazole	161	51
Levothyroxine Sodium	Levothyroxine Sodium	150	47
Tamsulosin Hcl	Tamsulosin Hcl	149	47
Hydrochlorothiazide	Hydrochlorothiazide	147	43
Gabapentin	Gabapentin	146	36
Metformin Hcl	Metformin Hcl	136	42
Rosuvastatin Calcium	Rosuvastatin Calcium	112	39
Furosemide	Furosemide	103	43
Metformin Hcl Er	Metformin Hcl	99	27
Tramadol Hcl	Tramadol Hcl	99	29
Finasteride	Finasteride	91	29
Prednisone	Prednisone	87	55
Atenolol	Atenolol	79	24
Chlorthalidone	Chlorthalidone	79	29
Celecoxib	Celecoxib	71	22
Fluticasone Propionate	Fluticasone Propionate	70	suppressed
Glipizide Er	Glipizide	64	18
Potassium Chloride	Potassium Chloride	63	19
Warfarin Sodium	Warfarin Sodium	60	17
Pioglitazone Hcl	Pioglitazone Hcl	57	17
Citalopram Hbr	Citalopram Hydrobromide	56	15
Eliquis	Apixaban	53	15
Trazodone Hcl	Trazodone Hcl	53	17
Pravastatin Sodium	Pravastatin Sodium	46	14
Alprazolam	Alprazolam	45	suppressed
Clonazepam	Clonazepam	45	12
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Ozempic	Semaglutide	45	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	14
Montelukast Sodium	Montelukast Sodium	44	19
Fluoxetine Hcl	Fluoxetine Hcl	42	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Glipizide	Glipizide	42	13
Spironolactone	Spironolactone	41	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Metoprolol Tartrate	Metoprolol Tartrate	40	13
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Allopurinol	Allopurinol	38	12
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	36	11
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Trulicity	Dulaglutide	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Irbesartan	Irbesartan	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Meloxicam	Meloxicam	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Azithromycin	Azithromycin	21	20
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Jardiance	Empagliflozin	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	13
Carvedilol	Carvedilol	18	suppressed
Digoxin	Digoxin	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Cephalexin	Cephalexin	16	16
Glimepiride	Glimepiride	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Estradiol	Estradiol	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Valsartan	Valsartan	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Estarylla	Norgestimate-Ethinyl Estradiol	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Teriflunomide	Teriflunomide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error